|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 238,000.00 KRW | -0.21% |
|
+9.43% | +31.49% |
| 02-05 | CVS Health to drop Amgen and Lilly's bone disease treatments from some drug lists (February 5) | RE |
| 01-30 | Celltrion Launches Autoimmune Drug Aptozma in Europe | MT |
EPS & Dividend: Celltrion, Inc.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | 660.4 | - | 457.9 | 721.2 | 719.1 | 716.9 | 714.9 |
| Rate of return | - | 0.38% | - | 0.25% | 0.4% | 0.3% | 0.3% | 0.3% |
| EPS 2 | 3,284 | 3,691 | 3,530 | 3,437 | 1,966 | 3,766 | 5,932 | 6,894 |
| Distribution rate | - | 17.9% | - | 13.3% | 36.7% | 19.1% | 12.1% | 10.4% |
| Reference price 2 | 309,911.93 | 174,344.89 | 146,978.02 | 184,523.81 | 180,288.46 | 238,000.00 | 238,000.00 | 238,000.00 |
| Nbr of stocks (in thousands) | 158,075 | 158,264 | 156,488 | 151,581 | 223,894 | 218,884 | 218,884 | - |
| Announcement Date | 22/02/21 | 16/02/22 | 03/03/23 | 29/02/24 | 25/02/25 | - | - | - |
1KRW in Million2KRW
Estimates
Past dividends: Celltrion, Inc.
| 28/12/2025 | Other Dividend 750 KRW |
| 26/12/2024 | Annual 750 KRW |
| 26/12/2023 | Annual 500 KRW |
| 27/12/2022 | Annual 375 KRW |
| 28/12/2021 | Annual 750 KRW |
Upcoming events: Celltrion, Inc.
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 0.3% | 0.3% | 63.34x | 3.02x | 12.92x | |
| 0.98% | 1.09% | 34.85x | 3.57x | 5.08x | |
| -.--% | -.--% | 106.86x | 9.59x | 6.79x | |
| -.--% | -.--% | 23.87x | 4.53x | 2.59x | |
| -.--% | -.--% | -17.42x | 11.86x | 4635.15x | |
| -.--% | -.--% | -36.13x | 48.11x | 13.71x | |
| -.--% | -.--% | 34.66x | 148.22x | 7.67x | |
| 0.99% | 1.16% | 24.59x | 2.19x | 2.04x | |
| - | - | - | - | - | |
| -.--% | -.--% | 24.5x | 12.13x | 3.84x | |
| Average | 0.25% | 0.28% | 28.79x | 27.02x | 521.09x | |
| Weighted average by Cap. | 0.31% | 0.35% | 40.74x | 17.26x | 403.89x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition